Hodgkin Lymphoma

Showing NaN - NaN of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

Active, not recruiting
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +5 more
  • Fountain Valley, California
  • +75 more
Dec 2, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +12 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +2 more
Feb 17, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)

Completed
  • Hodgkin Lymphoma
  • Duarte, California
  • +12 more
Nov 3, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Hodgkin Lymphoma Trial in Boston (Brentuximab Vedotin, Adriamycin, Dacarbazine)

Completed
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 10, 2020

Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
Feb 6, 2020

Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in United States (Sirolimus, Methotrexate, Tacrolimus)

Completed
  • Non-hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Atlanta, Georgia
  • +4 more
Jan 30, 2019

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
  • +2 more
  • Duarte, California
  • +2 more
Nov 19, 2018

Hodgkin Lymphoma Trial in Tampa, Boston (Brentuximab Vedotin, Adriamycin, vinblastine, and dacarbazine)

Completed
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Adriamycin, vinblastine, and dacarbazine
  • Tampa, Florida
  • +3 more
Jan 23, 2018

Hodgkin Lymphoma Trial in Boston (Avastin)

Terminated
  • Hodgkin Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 18, 2017

Hodgkin Lymphoma Trial in United States (Everolimus (RAD001))

Completed
  • Hodgkin Lymphoma
  • Everolimus (RAD001)
  • Los Angeles, California
  • +15 more
Apr 18, 2016